Clinical trialNCT01880723CompletedInterventional

Utilizing Exhaled Breathe Condensate Collection to Study Ion Regulation in Cystic Fibrosis

SponsorUniversity of ArizonaEnrollment32Cystic FibrosisHealthy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Our aims were to determine if exhaled breath condensate (EBC) could detect differences in ion regulation between cystic fibrosis (CF) and healthy and measure the effect of the albuterol on EBC ions in these populations. We hypothesized EBC chloride and sodium would be lower in CF patients at baseline and that albuterol would decrease EBC sodium and increase EBC chloride.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Asad Patanwalla, PharmD
Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona
Principal Investigator
clinicaltrials.gov ↗
Cori M Daines, MD
Department of Pediatrics- Pulmonology, Allergy and Immunology, University of Arizona, Tucson, Arizona
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Eric M Snyder, PhD
Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona
Principal Investigator
clinicaltrials.gov ↗
Hanna Phan, PharmD
Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona
Principal Investigator
clinicaltrials.gov ↗
Wayne J Morgan, MD
Department of Pediatrics- Pulmonology, Allergy and Immunology, University of Arizona, Tucson, Arizona
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Department of Pharmacy Practice and Science, University of Arizona, Tucson, Arizona
Tucson, Arizona, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Albuterol →Placebo saline

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2009
Primary completion: 31 Jul 2012
Completion: 31 Jan 2013
Last update posted: 29 Nov 2023
Registered enrollment: 32
Registry id: NCT01880723

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.